Evidence map›Paper›PMID 34458799›Full record

ArticleRSC chemical biology2021

Metathramycin, a new bioactive aureolic acid discovered by heterologous expression of a metagenome derived biosynthetic pathway.

Luke J Stevenson, Joe Bracegirdle, Liwei Liu, Abigail V Sharrock, David F Ackerley, Robert A Keyzers, Jeremy G Owen

Open access · goldAbstract read
In one paragraph

Article in RSC chemical biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Synthetic and systems biotechnology · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Luke J StevensonSchool of Biological Sciences, Victoria University of Wellington Wellington New Zealand jeremy.owen@vuw.ac.nz.ORCID https://orcid.org/0000-0002-1130-2747
Joe BracegirdleMaurice Wilkins Centre for Molecular Biodiscovery New Zealand.ORCID https://orcid.org/0000-0001-7725-3477
Liwei LiuSchool of Biological Sciences, Victoria University of Wellington Wellington New Zealand jeremy.owen@vuw.ac.nz.
Abigail V SharrockSchool of Biological Sciences, Victoria University of Wellington Wellington New Zealand jeremy.owen@vuw.ac.nz.ORCID https://orcid.org/0000-0003-2837-9481
David F AckerleySchool of Biological Sciences, Victoria University of Wellington Wellington New Zealand jeremy.owen@vuw.ac.nz.ORCID https://orcid.org/0000-0002-6188-9902
Robert A KeyzersMaurice Wilkins Centre for Molecular Biodiscovery New Zealand.ORCID https://orcid.org/0000-0002-7658-7421
Jeremy G OwenSchool of Biological Sciences, Victoria University of Wellington Wellington New Zealand jeremy.owen@vuw.ac.nz.ORCID https://orcid.org/0000-0003-4738-6628
Victoria University of Wellington · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial natural products have been a rich source of bioactive compounds for drug development, and advances in DNA sequencing, informatics and molecular biology have opened new avenues for their discovery. Here, we describe the isolation of an aureolic acid biosynthetic gene cluster from a metagenome library derived from a New Zealand soil sample. Heterologous expression of this pathway in

Identifiers

PMID34458799
PMCPMC8341913
OpenAlexW3128938717

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.